WFDC2 and ovarian cancer: HE4 served as a biomarker for the detection of ovarian cancer in women with a pelvic mass; the cut-off value of HE4 was 70 pmol/L and 140 pmol/L for premenopausal and postmenopausal women, respectively, according to the manufacturer's instructions.